Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate

Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).

ESMO real world data and digital oncology·2026

Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Life stage-specific marine migration and spatial behaviour of sea trout (Salmo trutta) from two coastal rivers.

Journal of fish biology·2025

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.

ESMO open·2025

CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptions.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025

Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study.

ESMO open·2024

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Dual alexithymia: A relational framework for clinical communication in oncology.

Seminars in oncology·2026

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

Seminars in oncology·2026

The role of fumarate and itaconate in tumor microenvironment.

Seminars in oncology·2026

Related Experiment Videos

Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage

Related Concept Videos

Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).

Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma.

Life stage-specific marine migration and spatial behaviour of sea trout (Salmo trutta) from two coastal rivers.

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.

CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptions.

Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Dual alexithymia: A relational framework for clinical communication in oncology.

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

The role of fumarate and itaconate in tumor microenvironment.

Related Experiment Videos

Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage...

Related Concept Videos

Related Articles

Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage